Kirkland & Ellis has advised Cinven on a public acquisition offer for all outstanding shares of SYNLAB AG. The Fifth Cinven Fund already owns approximately 43% of the SYNLAB shares and has entered into irrevocable undertakings and re-investment agreements with various shareholders of SYNLAB. The completion of the offer is subject to customary conditions, in […]
The post Kirkland Advises Cinven on Public Acquisition Offer for SYNLAB appeared first on Legal Desire Media and Insights.